Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories

Non-Invasive Assessment of Liver Disease in Patients with NAFLD

(2019) Laurent Castera et al.   GASTROENTEROLOGY

Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis

(2019) Javier Ampuero et al.   Clinical Gastroenterology and Hepatology

Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Non‐alcoholic Fatty Liver Disease

(2019) Fasiha Kanwal et al.   HEPATOLOGY

Nonalcoholic Fatty Liver Disease

(2019) Yan-Ci Zhao et al.   HYPERTENSION

Nonalcoholic fatty liver disease and hypertension

(2018) Dimitrios Oikonomou et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Mechanosensing by β1 integrin induces angiocrine signals for liver growth and survival

(2018) Linda Lorenz et al.   NATURE

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   JOURNAL OF HYPERTENSION

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Association between MRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease

(2017) Roberto Lorbeer et al.   JOURNAL OF HYPERTENSION

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

(2016) Stuart McPherson et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

(2015) Siddharth Singh et al.   Clinical Gastroenterology and Hepatology

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk

(2015) Ehimen C. Aneni et al.   JOURNAL OF HYPERTENSION

Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey

(2014) C. E. Ruhl et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries

(2013) Clara K. Chow   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase

(2011) Alejandro López-Suárez et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY